This article provides a comprehensive guide for researchers and drug development professionals facing the unique challenges of nucleic acid extraction from chemically treated samples.
GC bias, a pervasive technical artifact in next-generation sequencing (NGS), systematically distorts genomic coverage and compromises data integrity, posing a significant challenge in chemogenomics for drug discovery and biomarker identification.
High host DNA background remains a significant challenge in metagenomic next-generation sequencing (mNGS), particularly in clinical samples like blood, respiratory secretions, and tissues where host content can exceed 99%.
Generating high-yield next-generation sequencing (NGS) libraries from compound-treated cells is a common yet complex challenge in drug discovery and functional genomics.
This article explores the transformative impact of single-cell Next-Generation Sequencing (sc-NGS) on chemogenomics, the study of genome-wide compound interactions.
This article provides a comprehensive guide for researchers and drug development professionals on implementing automated Next-Generation Sequencing (NGS) workflows for high-throughput chemogenomics.
This comprehensive review explores the integration of next-generation sequencing (NGS) workflows for cell-free DNA (cfDNA) analysis to unlock chemogenomic biomarkers in precision oncology.
This article provides a comprehensive guide to enrichment strategies for chemogenomic next-generation sequencing (NGS) libraries, tailored for researchers, scientists, and drug development professionals.
This article explores the transformative role of Next-Generation Sequencing (NGS) in high-throughput chemical genetic interaction mapping, a cornerstone of modern drug discovery.
This article provides a comprehensive guide for researchers and drug development professionals on implementing multiplexing strategies in chemogenomic Next-Generation Sequencing (NGS) screens.